HuGE Literature Finder
Records
1
-
6
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver international : official journal of the International Association for the Study of the Liver 2017 09 37 (9): 1345-1353. De Mattia Elena, Cecchin Erika, Polesel Jerry, Lupo Francesco, Tiribelli Claudio, Crovatto Marina, Buonadonna Angela, Toffoli Giusep |
Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World journal of gastroenterology : WJG 2005 Feb 11 (6): 797-802. Huang May-Jen, Yang Sien-Sing, Lin Min-Shung, Huang Ching-Sh |
Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology (Baltimore, Md.) 2004 Apr 39 (4): 970-7. Ehmer U, Vogel A, Schütte JK, Krone B, Manns MP, Strassburg CP |
UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003 Jun 124 (7): 1802-8. Ockenga Johann, Vogel Arndt, Teich Niels, Keim Volker, Manns Michael P, Strassburg Christian |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: